Hou Z, Ma A, Mao J, Song D, Zhao X. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout. Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):895-909.
Yang B, Xin M, Liang S, Xu X, Cai T, Dong L, Wang C, Wang M, Cui Y, Song X, Sun J, Sun W. New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds. Front Pharmacol. 2022 Nov 22;13:1026246.
Wu L, Fan Y, Wang Y, Li Z, Mao D, Zhuang W. The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia. J Clin Lab Anal. 2021 Oct;35(10):e23949.
Fan J, Xie W, Ke H, Zhang J, Wang J, Wang H, Guo N, Bai Y, Lei X. Structural Basis for Inhibition of Urate Reabsorption in URAT1. JACS Au. 2025;5(3):1308-1319.